Fix Pharma Forecasts: Common Misinterpretations of the FDA Orange Book That Distort Market Forecasts
The Orange Book Isn’t a Crystal Ball—And Misreading It Can Cost You
If you’ve ever built a market forecast off the FDA’s Orange Book, you’re not alone. But a recent analysis from DrugPatentWatch highlights a problem that’s far too common in pharma plan…
